Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 5, 2007, Pages

  Kim, David D ^a   Sánchez, Fabiola A ^a   Durán, Ricardo G ^a   Kanetaka, Takehito ^a   Durán, Walter N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Complementary and alternative medicine; Radix Salvia miltiorrhizae; Tanshinone IIIA

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) METHYLARGININE; NITRIC OXIDE; SALVIA MILTIORRHIZA EXTRACT; TANSHINONE; HERBACEOUS AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE HERB; CONTROLLED STUDY; CREMASTER MUSCLE; DRUG MECHANISM; HAMSTER; KNOCKOUT MOUSE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENOVASCULAR HYPERTENSION; SALVIA MILTIORRHIZA; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; HYPERTENSION; METABOLISM; METHODOLOGY; MICROCIRCULATION; PATHOPHYSIOLOGY; SYRIAN HAMSTER; TREATMENT OUTCOME;

ANIMALS; CRICETINAE; DRUG DELIVERY SYSTEMS; DRUGS, CHINESE HERBAL; HYPERTENSION; MALE; MESOCRICETUS; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NITRIC OXIDE SYNTHASE TYPE II; TREATMENT OUTCOME;

EID: 34250830191     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01027.2006     Document Type: Article

References (44)

1. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, Van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 199: 8-17, 2003.
2. Bensky D, Gamble A, Kaptchuk T. Chinese Herbal Medicine: Materia Medica (2nd ed.). Seattle, WA: East, 1993, p. 267-268.
3. Bohlen HG, Nase GP. Dependence of intestinal arteriolar regulation on flow-mediated nitric oxide formation. Am J Physiol Heart Circ Physiol 279: H2249-H2258, 2000.
4. Boric MP, Roblero JS, Durán WN. Quantitation of bradykinin-induced microvascular leakage of FITC-dextran in rat cremaster muscle. Microvasc Res 33: 397-412, 1987.
5. Breslin JW, Pappas PJ, Cerveira JJ, Hobson RWII, Durán WN. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 284: H92-H100, 2003.
6. Brown J, reading SJ, Jones S, Fitchett CJ, Howl J, Martin A, Longland CL, Michelangeli F, Dubrova YE, Brown CA. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 80: 37-45, 2000.
7. Cui L, Wu T, Liu YY, Deng YF, Ai CM, Chen HQ. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats. Acta Pharmacol Sin 25: 678-684, 2004.
8. Dillon PK, Durán WN. The effect of platelet activating factor on microvascular permselectivity: dose-response relationships and pathways of action in the hamster cheek pouch microcirculation. Circ Res 62: 732-740, 1988.
9. Dillon PK, Ritter AB, Durán WN. Vasoconstrictor effects of platelet activating factor in the hamster cheek pouch microcirculation: dose-response relationships and pathways of action. Circ Res 62: 722-731, 1988.
10. Durán WN, Seyama A, Yoshimura K, González DR, Figueroa XF, Boric MP. Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. Microvasc Res 60: 104-111, 2000.
11. Fulton D, Gratton JP, Mccabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
12. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
13. Huang PL. Endothelial nitric oxide synthase and endothelial dysfunction. Curr Hypertens Rep 5: 473-480, 2003.
14. Ji XY, Tan BK, Zhu YZ. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol Sin 21: 1089-1094, 2000.
15. Kang DG, Yun YG, Ryoo JH, Lee HS. Anti-hypertensive effect of water extract of Danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am J Chin Med 30: 87-93, 2002.
16. Karmin O, Cheung F, Sung FL, Zhu DY, Siow YL. Effect of magnesium tanshinoate B on the production of nitric oxide in endothelial cells. Mol Cell Biochem 207: 35-39, 2000.
17. Kim DD, Pica AM, Durán RG, Durán WN. Acupuncture reduces experimental renovascular hypertension through mechanisms involving nitric oxide synthases. Microcirculation 13: 577-585, 2006.
18. Kim DD, Ramírez MM, Durán WN. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch. Microvasc Res 59: 7-13, 2000.
19. -). J Hypertens 20: 1581-1587, 2002.
20. Kwak HB, Yang D, Ha H, Lee JH, Kim HN, Woo ER, Lee S, Kim HH, Lee ZH. Tanshinone IIA inhibits osteoclast differentiation through downregulation of c-Fos and NFATc1. Exp Mol Med 38: 256-264, 2006.
21. Lam BY, Lo AC, Sun X, Luo HW, Chung SK, Sucher NJ. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine 10: 286-291, 2003.
22. Lam FF, Yeung JH, Cheung JH, Or PM. Pharmacological evidence for calcium channel inhibition by Danshen (Salvia miltiorrhiza) on rat isolated femoral artery. J Cardiovasc Pharmacol 47: 139-145, 2006.
23. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation 104: 735-740, 2001.
24. Li H, Wallerath T, Munzel T, Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7: 149-164, 2002.
25. Liu J, Hughes TE, Sessa WC. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J Cell Biol 137: 1525-1535, 1997.
26. Lu GW, Miura K, Yukimura T, Yamamoto K. Effects of extract from Clerodendron trichotomum on blood pressure and renal function in rats and dogs. J Ethnopharmacol 42: 77-82, 1994.
27. Niu XL, Ichimori K, Yang X, Hirota Y, Hoshiai K, Li M, Nakazawa H. Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic Res 33: 305-312, 2000.
28. Paxinou E, Weisse M, Chen Q, Souza JM, Hertkorn C, Selak M, Daikhin E, Yudkoff M, Sowa G, Sessa WC, Ischiropoulos H. Dynamic regulation of metabolism and respiration by endogenously produced nitric oxide protects against oxidative stress. Proc Natl Acad Sci USA 98: 11575-11580, 2001.
29. Prewitt RL, Rice DC, Dobrian AD. Adaptation of resistance arteries to increase in pressure. Microcirculation 9: 295-304, 2002.
30. Ramírez MM, Quardt SM, Kim D, Oshiro H, Minnicozzi M, Durán WN. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc Res 50: 223-234, 1995.
31. Sánchez FA, Savalia NB, Durán RG, Lal BK, Boric MP, Durán WN. Functional significance of differential eNOS translocation. Am J Physiol Heart Circ Physiol 291: H1058-H1064, 2006.
32. Searles CD. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am J Physiol Cell Physiol 291: C803-C816, 2006.
33. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressure in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93: 13176-13181, 1996.
34. Sowa G, Liu J, Papapetropoulos A, Rex-Haffner M, Hughes TE, Sessa WC. Trafficking of endothelial nitric-oxide synthase in living cells. Quantitative evidence supporting the role of palmitoylation as a kinetic trapping mechanism limiting membrane diffusion. J Biol Chem 274: 22524-22531, 1999.
35. Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A, Azuma J. Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochem Pharmacol 64: 745-749, 2002.
36. Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 26: 265-274, 1990.
37. Takenaka H, Oshiro H, Kim DD, Thompson PN, Seyama A, Hobson RW II, Durán WN. Microvascular transport is associated with TNF plasma levels and protein synthesis in postischemic muscle. Am J Physiol Heart Circ Physiol 274: H1914-H1919, 1998.
38. Vicaut E. Microcirculation and arterial hypertension. Drugs 58: 1-10, 1999.
39. Wang AM, Sha SH, Lesniak W, Schacht J. Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 47: 1836-1841, 2003.
40. Xia WJ, Yang M, Fok TF, Li K, Chan WY, Ng PC, Ng HK, Chik KW, Wang CC, Gu GJ, Woo KS, Fung KP. Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatr Res 58: 784-790, 2005.
41. Zhang H, Yu C, Jia JY, Leung SW, Siow YL, Man RY, Zhu DY. Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza). Acta Phamacol Sin 23: 1163-1168, 2002.
42. Zhou GY, Zhao BL, Hou JW, Ma GE, Xin WJ. Protective effects of sodium tanshinone IIA sulphonate against adriamycin-induced lipid peroxidation in mice hearts in vivo and in vitro. Pharmacol Res 40: 487-491, 1999.
43. Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345-59, 2005.
44. Zhou Z, Wang SQ, Liu Y, Miao AD. Cryptotanshinone inhibits endothelin-1 expression and stimulates nitric oxide production in human vascular endothelial cells. Biochim Biophys Acta 1760: 1-9, 2006.